HomeAI · summaries
Storia in 2 fonti
Hormone therapy may lower risk for CVD among midlife women
Women in midlife with vasomotor symptoms who initiated menopausal hormone therapy, or MHT, during perimenopause or shortly after menopause had a 22% lower risk for CVD, new data show.Prior literature in this area is mixed, with studies capturing both beneficial and adverse impacts of MHT on cardiovascular health, according to Ziyuan Wang, PhD, an advisor pharmacoepidemiology at Eli Lilly and
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Hormone therapy may lower risk for CVD among midlife women
Women in midlife with vasomotor symptoms who initiated menopausal hormone therapy, or MHT, during perimenopause or shortly after menopause had a 22% lower risk for CVD, new data…
- ·
medpagetoday.com
Menopausal Hormone Therapy May Bolster Heart Health
Timing of initiation and race appear to play a role in who may benefit